Sarmoko, Sarmoko and Novitasari, Dhania and Toriyama, Manami and Fareza, Muhamad Salman and Choironi, Nur Amalia and Itoh, Hiroshi and Meiyanto, Edy (2023) Different Modes of Mechanism of Gamma-Mangostin and Alpha-Mangostin to Inhibit Cell Migration of Triple-Negative Breast Cancer Cells Concerning CXCR4 Downregulation and ROS Generation. Iranian Journal of Pharmaceutical Research, 22 (1): e138856. ISSN 17350328
Different Modes of Mechanism of Gamma-Mangostin and Alpha-Mangostin to Inhibit Cell Migration of Triple-Negative Breast Cancer Cells Concerning CXCR4 Downregulation and ROS Generation.pdf
Restricted to Registered users only
Download (3MB) | Request a copy
Abstract
Background: Two mangostin compounds, gamma-mangostin and alpha-mangostin, show anticancer properties through the inhibition of cell proliferation and cell migration. Metastatic triple-negative breast cancer (TNBC) cells, including MDA-MB-231, highly express C-X-C chemokine receptor type 4 (CXCR4) to maintain reactive oxygen species (ROS) and cell migration. Objectives: This study was performed to analyze and compare different modes of action of γ-mangostin and α-mangostin as antimigratory effects targeted on CXCR4 in MDA-MB-231 as a model of TNBC cell. Methods: This study investigated the effect of γ-mangostin and α-mangostin using a series of assays, including Cell Counting Kit- 8 (CCK-8) assay for cytotoxicity, wound healing assay for migration study, quantitative real-time polymerase chain reaction (qRT-PCR) for gene expression analysis, and flow cytometry for ROS measurement, along with in silico study to observe the binding between the compound and CXCR4. Results: The findings revealed half maximal inhibitory concentration (IC50) values of 25 and 20μM for γ-mangostin and α-mangostin in MDA-MB 231 cells, respectively. Moreover, a concentration of 10μM was used for the migration assay. Both γ-mangostin and α-mangostin significantly suppressed cell migration within 24 hours. The present gene expression studies revealed the downregulation of key migration-associated genes, namely Farp, CXCR4, and LPHN2, upon γ-mangostin treatment but not α-mangostin. Additionally, both γ-mangostin and α-mangostin increased cellular ROS generation, highlighting the same effect of γ-mangostin and α-mangostin ROS elevation to inhibit cancer cell migration. Molecular docking simulations further suggested a potential interaction between γ-mangostin and α-mangostin with CXCR4 in high affinity. Conclusions: These findings suggest that both γ-mangostin and α-mangostin inhibit breast cancer cell migration and induce cellular ROS levels in MDA-MB-231 cells; notably, γ-mangostin suppresses CXCR4 mRNA expression that might correlate to its activity to inhibit MDA-MB-231 cell migration. © 2023, Brieflands. All rights reserved.
Item Type: | Article |
---|---|
Additional Information: | Cited by: 1; All Open Access, Hybrid Gold Open Access |
Uncontrolled Keywords: | alpha mangostin plant extract; antineoplastic agent; chemokine receptor CXCR4; gamma mangostin plant extract; plant extract; Rac1 protein; reactive oxygen metabolite; unclassified drug; Article; bioinformatics; cell migration; cell viability; clinical trial; controlled clinical trial; controlled study; cytotoxicity assay; farp gene; flow cytometry; Garcinia mangostana; human; human cell; IC50; LPHN2 gene; MDA-MB-231 cell line; migration inhibition; molecular docking; mRNA expression level; real time polymerase chain reaction; triple negative breast cancer; wound healing assay |
Subjects: | R Medicine > RB Pathology |
Divisions: | Faculty of Medicine, Public Health and Nursing > Biomedical Sciences |
Depositing User: | Ani PURWANDARI |
Date Deposited: | 16 May 2024 02:23 |
Last Modified: | 16 May 2024 02:23 |
URI: | https://ir.lib.ugm.ac.id/id/eprint/1176 |